​

CASI Pharmaceuticals (CASI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CASI Stock Forecast

CASI Pharmaceuticals (CASI) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 153.16% increase from the last price of $2.37.

$2 $3 $4 $5 $6 $7 $8 High: $6 Avg: $6 Low: $6 Last Closed Price: $2.37

CASI Stock Rating

CASI Pharmaceuticals stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 2 Strong Sell Sell Hold Buy Strong Buy

CASI Forecast vs Benchmarks

TypeNameUpside
StockCASI Pharmaceuticals153.16%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$6.00
Last Closing Price$2.37$2.37$2.37
Upside/Downside--153.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24-2---2
Oct, 24-2---2
Sep, 24-2---2
Aug, 24-2---2
Jul, 24-1---1
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2024Sean LeeH.C. Wainwright$6.00$3.2684.05%153.16%
Aug 15, 2022H.C. Wainwright$12.00$4.02198.51%406.33%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2024H.C. WainwrightBuyBuyhold
Nov 16, 2022BTIGBuyBuyhold
Jun 03, 2022BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.66$-2.78$-2.89$-2.02-----
Avg Forecast$-3.56$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
High Forecast$-3.56$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
Low Forecast$-3.56$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
Surprise %58.99%-8.25%153.51%4.66%-----

Revenue Forecast

$10M $30M $50M $70M $90M $110M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.14M$30.17M$43.11M$33.88M-----
Avg Forecast$14.69M$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
High Forecast$14.69M$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
Low Forecast$14.69M$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
Surprise %3.05%0.29%2.44%-6.97%-----

Net Income Forecast

$-65M $-55M $-45M $-35M $-25M $-15M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.57M$-37.77M$-39.41M$-26.94M-----
Avg Forecast$-47.52M$-40.53M$-33.37M$-26.96M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
High Forecast$-47.52M$-40.53M$-40.04M$-32.35M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
Low Forecast$-47.52M$-40.53M$-26.69M$-21.57M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
Surprise %31.66%-6.80%18.12%-0.08%-----

CASI Forecast FAQ

Is CASI Pharmaceuticals stock a buy?

CASI Pharmaceuticals stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CASI Pharmaceuticals is a favorable investment for most analysts.

What is CASI Pharmaceuticals's price target?

CASI Pharmaceuticals's price target, set by 2 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 153.16% change from the previous close price of $2.37.

How does CASI Pharmaceuticals stock forecast compare to the average forecast of its sector, industry, and investment themes?

CASI Pharmaceuticals stock forecast shows a 153.16% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for CASI Pharmaceuticals over the past three months?

  • November 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CASI Pharmaceuticals’s EPS forecast?

CASI Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December is -2.56 for 2024, a 26.73% increase from the reported $-2.02 in 2023. The prediction for 2025 is $-2.13, $-1.75 for 2026, $-1.62 for 2027, and $-1.36 for 2028.

What is CASI Pharmaceuticals’s revenue forecast?

CASI Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December is $19.8M for 2024, a -41.57% decrease from the reported $33.88M in 2023. The forecast for 2025 is $46.48M, $70.35M for 2026, $89.46M for 2027, and $108.07M for 2028.

What is CASI Pharmaceuticals’s net income forecast?

For its fiscal year ending in December, CASI Pharmaceuticals's average annual net income forecast is $-34.202M for 2024, reflecting an 26.97% increase from the reported $-26.938M in 2023. The projection for 2025 is $-28.457M, $-23.38M for 2026, $-21.644M for 2027, and $-18.17M for 2028.